Literature DB >> 1112456

Sulfated and nonsulfated bile acids in urine, serum, and bile of patients with hepatobiliary diseases.

I Makino, H Hashimoto, K Shinozaki, K Yoshino, S Nakagawa.   

Abstract

Large amounts of bile acid sulfate were found in the urine of patients with hepatobiliary diseases. In patients with acute hepatitis, daily excretion of bile acid into urine was 68.24 plus or minus 51.80 mumoles per day, and the percentage of sulfated bile acid was 83.4 plus or minus 16.7%. In patients with chronic hepatitis and cirrhosis, a slight increase of urinary bile acid was observed (2.89 plus or minus 2.69 and 5.27 plus or minus 4.28 mumoles per day, respectively), and the percentage of sulfated bile acid was 73.9 plus or minus 28.6 and 44.6 plus or minus 30.4%, respectively. In patients with obstructive jaundice, a moderate increase of urinary bile acid was found (32.62 plus or minus 18.35 mumoles per day), and the percentage of sulfated bile acid was 58.3 plus or minus 22.6%. In patients with hepatobiliary diseases, the elevation of both levels of sulfated and nonsulfated bile acids in serum was observed. The percentage of sulfated bile acid was 9% in normal serum, and varied from zero to 82.8% in pathological sera. A remarkable increase of sulfated bile acid was found in patients with obstructive juandice and acute hepatitis, while a slight elevation was found in patients with chronic hepatitis and cirrhosis. Sulfated bile acid in bile was nonexistent or below 0.5% of total bile acid. According to these findings, the increased bile acid in serum of patients with hepatobiliary diseases might be more easily excreted into the urine as sulfated bile acid.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1112456

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  46 in total

1.  Separate transport systems for biliary secretion of sulfated and unsulfated bile acids in the rat.

Authors:  F Kuipers; M Enserink; R Havinga; A B van der Steen; M J Hardonk; J Fevery; R J Vonk
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

2.  Postprandial serum bile acids in healthy man. Evidence for differences in absorptive pattern between individual bile acids.

Authors:  B Angelin; I Björkhem
Journal:  Gut       Date:  1977-08       Impact factor: 23.059

3.  Bile acid excretion: the alternate pathway in the hamster.

Authors:  R Galeazzi; N B Javitt
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

4.  The role of tubular reabsorption in the renal excretion of bile acids.

Authors:  S Barnes; J L Gollan; B H Billing
Journal:  Biochem J       Date:  1977-07-15       Impact factor: 3.857

5.  Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA).

Authors:  O Chazouillères; P Marteau; M Haniche; R Jian; R Poupon
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

6.  Will the real bile acid sulfotransferase please stand up? Identification of Sult2a8 as a major hepatic bile acid sulfonating enzyme in mice.

Authors:  Paul A Dawson; Kenneth D R Setchell
Journal:  J Lipid Res       Date:  2017-04-28       Impact factor: 5.922

7.  Altered bile acid metabolism in primary biliary cirrhosis.

Authors:  R Raedsch; B H Lauterburg; A F Hofmann
Journal:  Dig Dis Sci       Date:  1981-05       Impact factor: 3.199

8.  Serum bile acids in the diagnosis of hepatobiliary disease.

Authors:  C R Pennington; P E Ross; I A Bouchier
Journal:  Gut       Date:  1977-11       Impact factor: 23.059

9.  Clinical significance of serum bile acid measurement in liver diseases.

Authors:  T Morita; Y Matsuyama; T Fujimoto; M Higuchi; T Tsujii; Y Matsuoka
Journal:  Gastroenterol Jpn       Date:  1978

10.  Effect of taurolithocholate on in vivo sulfation and glucuronidation of acetaminophen in rats.

Authors:  R E Galinsky; B Chałasinska
Journal:  Pharm Res       Date:  1988-01       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.